These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10202728)

  • 1. Effect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusis.
    Lenton LM; Albietz JM
    J Refract Surg; 1999; 15(2 Suppl):S227-31. PubMed ID: 10202728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface management of photorefractive keratectomy and laser in situ keratomileusis.
    Albietz JM; McLennan SG; Lenton LM
    J Refract Surg; 2003; 19(6):636-44. PubMed ID: 14640428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous serum eye drops for dry eye after LASIK.
    Noda-Tsuruya T; Asano-Kato N; Toda I; Tsubota K
    J Refract Surg; 2006; 22(1):61-6. PubMed ID: 16447938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface.
    Battat L; Macri A; Dursun D; Pflugfelder SC
    Ophthalmology; 2001 Jul; 108(7):1230-5. PubMed ID: 11425680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments.
    Albietz JM; Bruce AS
    Curr Eye Res; 2001 Jan; 22(1):8-18. PubMed ID: 11402374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients.
    Albietz JM; Lenton LM; McLennan SG; Earl ML
    CLAO J; 2002 Apr; 28(2):96-100. PubMed ID: 12054380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser in situ keratomileusis for myopia and astigmatism: 6 month results.
    Dulaney DD; Barnet RW; Perkins SA; Kezirian GM
    J Cataract Refract Surg; 1998 Jun; 24(6):758-64. PubMed ID: 9642584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study.
    Sanchez MA; Torralbo-Jimenez P; Giron N; de la Heras B; Herrero Vanrell R; Arriola-Villalobos P; Diaz-Valle D; Alvarez-Barrientos A; Benitez-Del-Castillo JM
    Cornea; 2010 Feb; 29(2):167-71. PubMed ID: 20023577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E; Yaylali V; Cetin EN; Yildirim C
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of laser in situ keratomileusis for hyperopia on tear film and ocular surface.
    Albietz JM; Lenton LM; McLennan SG
    J Refract Surg; 2002; 18(2):113-23. PubMed ID: 11934197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical diclofenac and prednisolone eyedrops in laser in situ keratomileusis patients.
    Vantesone DL; Luna JD; Muiño JC; Juárez CP
    J Cataract Refract Surg; 1999 Jun; 25(6):836-41. PubMed ID: 10374166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser in situ keratomileusis for low myopia and astigmatism with a scanning spot excimer laser.
    Zaldivar R; Davidorf JM; Shultz MC; Oscherow S
    J Refract Surg; 1997; 13(7):614-9. PubMed ID: 9427198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser in situ keratomileusis for myopia from -5.50 to -11.50 diopters with astigmatism.
    Zaldivar R; Davidorf JM; Oscherow S
    J Refract Surg; 1998; 14(1):19-25. PubMed ID: 9531081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results and complications of laser in situ keratomileusis by experienced surgeons.
    Davidorf JM; Zaldivar R; Oscherow S
    J Refract Surg; 1998; 14(2):114-22. PubMed ID: 9574741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser in situ keratomileusis for moderate and high myopia and myopic astigmatism.
    Knorz MC; Wiesinger B; Liermann A; Seiberth V; Liesenhoff H
    Ophthalmology; 1998 May; 105(5):932-40. PubMed ID: 9593400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tear film and ocular surface management on myopic LASIK outcomes.
    Albietz J; Lenton L; McLennan S
    Adv Exp Med Biol; 2002; 506(Pt A):711-7. PubMed ID: 12613982
    [No Abstract]   [Full Text] [Related]  

  • 17. Goblet cell response after photorefractive keratectomy and laser in situ keratomileusis.
    Ryan DS; Bower KS; Sia RK; Shatos MA; Howard RS; Mines MJ; Stutzman RD; Dartt DA
    J Cataract Refract Surg; 2016 Aug; 42(8):1181-9. PubMed ID: 27531295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of punctal occlusion in management of dry eyes after laser in situ keratomileusis for myopia.
    Alfawaz AM; Algehedan S; Jastaneiah SS; Al-Mansouri S; Mousa A; Al-Assiri A
    Curr Eye Res; 2014 Mar; 39(3):257-62. PubMed ID: 24147767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excimer laser in situ keratomileusis to correct compound myopic astigmatism.
    el Danasoury MA; Waring GO; el Maghraby A; Mehrez K
    J Refract Surg; 1997; 13(6):511-20. PubMed ID: 9352479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.